A Phase I Clinical Trial of BAT4306F (for injection) on Safety, Tolerability and Pharmacokinetics for Patients with CD20-positive, B-cell non-Hodgkin's lymphoma
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 25 Oct 2018
At a glance
- Drugs BAT-4306F (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions; Pharmacokinetics
- 16 Oct 2018 Status changed from planning to not yet recruiting.
- 05 Apr 2018 New trial record
- 30 Mar 2018 According to a Bio-Thera Solutions media release, this trial is anticipated to start during the second quarter of 2018.